Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.

Eve Mary Dorothy SmithE Al-AbadiK ArmonK BaileyCoziana CiurtinJ DavidsonJ Gardner-MedwinK HaslamD HawleyA LeahyV LeoneF McErlaneD MewarG ModgilR MootsC PilkingtonA RamananS RangarajP RileyA SridharN WilkinsonM W BeresfordC M Hedrich

Published in: Lupus (2019)

This is the largest study to date investigating induction treatments for proliferative LN in children, demonstrating comparability of MMF and IVCYC.

Keyphrases

young adults
high dose